scispace - formally typeset
M

Marcin Kurzyna

Researcher at Medical University of Warsaw

Publications -  165
Citations -  8139

Marcin Kurzyna is an academic researcher from Medical University of Warsaw. The author has contributed to research in topics: Pulmonary hypertension & Medicine. The author has an hindex of 28, co-authored 139 publications receiving 7305 citations.

Papers
More filters
Journal ArticleDOI

Sildenafil citrate therapy for pulmonary arterial hypertension.

TL;DR: Among the 222 patients completing one year of treatment with sildenafil monotherapy, the improvement from baseline at one year in the distance walked in six minutes was 51 m, and the incidence of clinical worsening did not differ significantly between the patients treated with s Bildenafils and those treated with placebo.
Journal ArticleDOI

Definitions and diagnosis of pulmonary hypertension.

TL;DR: Early diagnosis of PAH remains difficult, and screening programs in asymptomatic patients are feasible only in high-risk populations, particularly in patients with systemic sclerosis, for whom recent data suggest that a combination of clinical assessment and pulmonary function testing has a higher predictive value than echocardiography alone.
Journal ArticleDOI

Definitions and diagnosis of pulmonary hypertension

TL;DR: Pulmonary arterial hypertension (PAH) describes a subpopulation of patients with PH characterized hemodynamically by the presence of pre-capillary PH including an end-expiratory pulmonary artery wedge pressure (PAWP) 15 mm Hg and a pulmonary vascular resistance > 3 Wood units as discussed by the authors.
Journal ArticleDOI

Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.

TL;DR: A serum NT-proBNP level of > or = 1,400 pg/mL was found to be useful in identifying patients with poor long-term prognosis both in the whole studied group and in the IPAH subgroup.